Kuracado kaj traktado de la kronvirusa malsano de 2019 (Esperanto Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kuracado kaj traktado de la kronvirusa malsano de 2019" in Esperanto language version.

refsWebsite
Global rank Esperanto rank
2nd place
7th place
1st place
1st place
195th place
64th place
4th place
9th place
49th place
103rd place
1,169th place
2,882nd place
5,712th place
4,358th place
218th place
212th place
896th place
268th place
8th place
19th place
3,258th place
8,026th place
low place
low place
702nd place
724th place

bbc.co.uk

cdc.gov

doi.org

  • (July 2020) “Drug treatments for covid-19: living systematic review and network meta-analysis”, BMJ 370, p. m2980. doi:10.1136/bmj.m2980. 
  • (July 2021) “SARS-CoV-2 Antiviral Therapy”, Clinical Microbiology Reviews, p. e0010921. doi:10.1128/CMR.00109-21. 236472654. 
  • (February 2020) “Q&A: The novel coronavirus outbreak causing COVID-19”, BMC Medicine 18 (1), p. 57. doi:10.1186/s12916-020-01533-w. 
  • (March 2020) “Comorbidities and multi-organ injuries in the treatment of COVID-19”, Lancet 395 (10228), p. e52. doi:10.1016/s0140-6736(20)30558-4. 
  • (March 2020) “Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures”, Journal of Medical Virology 92 (6), p. 568–576. doi:10.1002/jmv.25748. 
  • (May 2020) “Could nasal breathing help to mitigate the severity of COVID-19”, Microbes and Infection 22 (4–5), p. 168–171. doi:10.1016/j.micinf.2020.05.002. 
  • (March 2020) “Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence”, International Journal of Antimicrobial Agents 55 (6), p. 105948. doi:10.1016/j.ijantimicag.2020.105948. 
  • (November 2020) “Update to living WHO guideline on drugs for covid-19”, BMJ (Clinical Research Ed.) 371, p. m4475. doi:10.1136/bmj.m4475. 227059995. 
  • (April 2020) “COVID-19, ECMO, and lymphopenia: a word of caution”, The Lancet. Respiratory Medicine 8 (4), p. e24. doi:10.1016/s2213-2600(20)30119-3. 
  • (2021) “Immunopathogenesis and treatment of cytokine storm in COVID-19”, Theranostics 11 (1), p. 316–329. doi:10.7150/thno.49713. 
  • (December 2020) “Therapy for Early COVID-19: A Critical Need”, JAMA 324 (21), p. 2149–2150. doi:10.1001/jama.2020.22813. 
  • (November 2020) “Covid-19: What now for remdesivir?”, BMJ 371, p. m4457. doi:10.1136/bmj.m4457. 
  • (April 2020) “2019 Novel coronavirus: where we are and what we know”, Infection 48 (2), p. 155–163. doi:10.1007/s15010-020-01401-y. 

emcrit.org

hopkinsmedicine.org

nice.org.uk

nih.gov

covid19treatmentguidelines.nih.gov

reuters.com

scientificamerican.com

upenn.edu

guides.library.upenn.edu

web.archive.org

webmd.com

who.int